Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2009

01.12.2009 | Gynecologic Oncology

Analysis of Contemporary Trends in Access to High-Volume Ovarian Cancer Surgical Care

verfasst von: Robert E. Bristow, MD, FACS, Isha Puri, MD, Teresa P. Diaz-Montes, MD, MPH, Robert L. Giuntoli, MD, FACS, Deborah K. Armstrong, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Positive volume-outcome relationships exist for cancers treated with technically complex surgery, including ovarian cancer. However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined.

Methods

The Maryland Health Service Cost Review Commission database was accessed for annual hospital and surgeon primary ovarian cancer surgical case volume for 2001–2008 and evaluated for statistically significant trends in access to high-volume surgical care compared with the earlier period for 1990–2000. χ2 and logistic regression analyses were used to evaluate for significant trends in case volume distribution over time as well as factors associated with access to high-volume care.

Results

Overall, 2,475 primary ovarian cancer operations were performed by 472 surgeons at 43 hospitals. There was a statistically significant increase in the proportion of cases performed at high-volume centers from 22.8% in 1990–2000 to 61.1% in 2001–2008 (odds ratio = 5.30, 95% confidence interval = 4.68–6.00, P < .0001), while low-volume hospital case distribution decreased from 49.6 to 31.3%. Access to high-volume surgeons increased from 34.5% in 1990–2000 to 64.5% in 2001–2008 (odds ratio = 3.44, 95% confidence interval = 3.06–3.87, P < .0001), while the proportion of cases performed by low-volume surgeons decreased from 56.3 to 28.9%. After controlling for other variables, high-volume surgeons were significantly more likely to perform ovarian cancer surgery that included hysterectomy and staging/cytoreductive surgical procedures.

Conclusions

The proportions of ovarian cancer patients undergoing primary surgery at high volume centers and by high-volume surgeons increased statistically significantly from 1990–2000 to 2001–2008. Further investigation is necessary to determine factors contributing to this favorable trend.
Literatur
1.
2.
Zurück zum Zitat Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.CrossRefPubMed Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.CrossRefPubMed
3.
Zurück zum Zitat Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol. 2002;84:36–42.CrossRefPubMed Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol. 2002;84:36–42.CrossRefPubMed
4.
Zurück zum Zitat Grossi M, Quin MA, Thursfield VJ, et al. Ovarian cancer: patterns of care in Victoria during 1993–1995. Med J Aust. 2002;177:11–1. Grossi M, Quin MA, Thursfield VJ, et al. Ovarian cancer: patterns of care in Victoria during 1993–1995. Med J Aust. 2002;177:11–1.
5.
Zurück zum Zitat Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47:203–9.CrossRefPubMed Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47:203–9.CrossRefPubMed
6.
Zurück zum Zitat Engelen MJA, Kos HE, Willemse PHB, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer. 2006;106:589–98.CrossRefPubMed Engelen MJA, Kos HE, Willemse PHB, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer. 2006;106:589–98.CrossRefPubMed
7.
Zurück zum Zitat Olaitan A, Weeks J, Mocroft A, et al. The surgical management of women with ovarian cancer in the south west of England. Br J Cancer. 2001;85:1824–30.CrossRefPubMed Olaitan A, Weeks J, Mocroft A, et al. The surgical management of women with ovarian cancer in the south west of England. Br J Cancer. 2001;85:1824–30.CrossRefPubMed
8.
Zurück zum Zitat Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol. 2002;87:260–7.CrossRefPubMed Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol. 2002;87:260–7.CrossRefPubMed
9.
Zurück zum Zitat Vernooji F, Heintz APM, Witteveen PO, et al. Specialized care and survival of ovarian cancer patients in the Netherlands: nationwide cohort study. J Natl Cancer Inst. 2008;100:399–406.CrossRef Vernooji F, Heintz APM, Witteveen PO, et al. Specialized care and survival of ovarian cancer patients in the Netherlands: nationwide cohort study. J Natl Cancer Inst. 2008;100:399–406.CrossRef
10.
Zurück zum Zitat Hillner BE, Smith TJ, Desch CE. Hospital and physician volume of specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327–40.PubMed Hillner BE, Smith TJ, Desch CE. Hospital and physician volume of specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327–40.PubMed
11.
Zurück zum Zitat Bristow RE, Zahurak ML, del Carmen MG, et al. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004;93:353–60.CrossRefPubMed Bristow RE, Zahurak ML, del Carmen MG, et al. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004;93:353–60.CrossRefPubMed
12.
Zurück zum Zitat Cox DR. The analysis of binary data. London: Methuen, 1970. Cox DR. The analysis of binary data. London: Methuen, 1970.
13.
Zurück zum Zitat SAS Institute Inc. SAS user’s guide: statistics, 5th ver ed. Cary, NC: SAS Institute, 1985. SAS Institute Inc. SAS user’s guide: statistics, 5th ver ed. Cary, NC: SAS Institute, 1985.
14.
Zurück zum Zitat Hoskins W, Rice L, Rubin S. Ovarian cancer surgical practice guidelines. Oncology. 1997;11:896–904.PubMed Hoskins W, Rice L, Rubin S. Ovarian cancer surgical practice guidelines. Oncology. 1997;11:896–904.PubMed
15.
Zurück zum Zitat Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 1999;93:448–52.CrossRefPubMed Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 1999;93:448–52.CrossRefPubMed
16.
Zurück zum Zitat du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer. 2005;15:183–91.CrossRefPubMed du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer. 2005;15:183–91.CrossRefPubMed
17.
Zurück zum Zitat du Bois A, Rochon J, Pfisterer J, Hoskins WJ. Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol. 2009;112:422–36.CrossRefPubMed du Bois A, Rochon J, Pfisterer J, Hoskins WJ. Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol. 2009;112:422–36.CrossRefPubMed
18.
Zurück zum Zitat Kumpulainen S, Grenman S, Kyyronen P, Pukkula E, Sankila R. Evidence of benefit from centralized treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer. 2002;102:541–4.CrossRefPubMed Kumpulainen S, Grenman S, Kyyronen P, Pukkula E, Sankila R. Evidence of benefit from centralized treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer. 2002;102:541–4.CrossRefPubMed
19.
Zurück zum Zitat Ioka A, Tsukuma H, Ajiki W, Oshima A. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci. 2004;95:233–7.CrossRefPubMed Ioka A, Tsukuma H, Ajiki W, Oshima A. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci. 2004;95:233–7.CrossRefPubMed
20.
Zurück zum Zitat Oberainger W, Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancers—a population-based study in Tyeol, Austria. Gynecol Oncol. 2006;103:527–34.CrossRef Oberainger W, Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancers—a population-based study in Tyeol, Austria. Gynecol Oncol. 2006;103:527–34.CrossRef
21.
Zurück zum Zitat Goff BA, Matthews BJ, Wynn M, et al. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol. 2006;103:383–90.CrossRefPubMed Goff BA, Matthews BJ, Wynn M, et al. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol. 2006;103:383–90.CrossRefPubMed
22.
Zurück zum Zitat Schrag D, Earle C, Xu F, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006;98:163–71.PubMed Schrag D, Earle C, Xu F, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006;98:163–71.PubMed
23.
Zurück zum Zitat Goff BA, Matthews BJ, Larson EH, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109:2031–42.CrossRefPubMed Goff BA, Matthews BJ, Larson EH, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109:2031–42.CrossRefPubMed
24.
Zurück zum Zitat Marx C, Bendixen A, Høgdall C, et al. Organisation and quality of primary surgical intervention for ovarian cancer in Denmark. Acta Obstet Gynecol. 2007;86:1496–502.CrossRef Marx C, Bendixen A, Høgdall C, et al. Organisation and quality of primary surgical intervention for ovarian cancer in Denmark. Acta Obstet Gynecol. 2007;86:1496–502.CrossRef
25.
Zurück zum Zitat Marth C, Hieble S, Oberainger W, et al. Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology. Int J Gynecol Cancer. 2009;19:94–102.PubMed Marth C, Hieble S, Oberainger W, et al. Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology. Int J Gynecol Cancer. 2009;19:94–102.PubMed
26.
Zurück zum Zitat Münstedt K, von Georgi R, Misselwitz B, et al. Centralizing surgery for gynecologic oncology—a strategy assuring better quality treatment? Gynecol Oncol. 2003;89:4–8.CrossRefPubMed Münstedt K, von Georgi R, Misselwitz B, et al. Centralizing surgery for gynecologic oncology—a strategy assuring better quality treatment? Gynecol Oncol. 2003;89:4–8.CrossRefPubMed
27.
Zurück zum Zitat O’Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994–1996: a population-based study. Gynecol Oncol. 2003;91:608–15.CrossRefPubMed O’Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994–1996: a population-based study. Gynecol Oncol. 2003;91:608–15.CrossRefPubMed
28.
Zurück zum Zitat Paulsen T, Kjaerheim K, Kaern J, Tretli S, Trope C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006;16:11–7.CrossRefPubMed Paulsen T, Kjaerheim K, Kaern J, Tretli S, Trope C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006;16:11–7.CrossRefPubMed
29.
Zurück zum Zitat Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003;102:499–505.CrossRefPubMed Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003;102:499–505.CrossRefPubMed
30.
Zurück zum Zitat Woodman C, Baghdady A, Collins S, Clyma JA. What changes in the organization of cancer services will improve the outcome for women with ovarian cancer? Br J Obstet Gynaecol. 1997;104:135–9.PubMed Woodman C, Baghdady A, Collins S, Clyma JA. What changes in the organization of cancer services will improve the outcome for women with ovarian cancer? Br J Obstet Gynaecol. 1997;104:135–9.PubMed
31.
Zurück zum Zitat Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999;106:1130–6.PubMed Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999;106:1130–6.PubMed
32.
Zurück zum Zitat Kumpulainen S, Kuoppala T, Leminen A, et al. Surgical treatment of ovarian cancer in different hospital categories—a prospective nation-wide study in Finland. Eur J Cancer. 2006;42:388–95.CrossRefPubMed Kumpulainen S, Kuoppala T, Leminen A, et al. Surgical treatment of ovarian cancer in different hospital categories—a prospective nation-wide study in Finland. Eur J Cancer. 2006;42:388–95.CrossRefPubMed
33.
Zurück zum Zitat Chan JK, Kapp DS, Shin JY, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007;109:1342–50.PubMed Chan JK, Kapp DS, Shin JY, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007;109:1342–50.PubMed
34.
Zurück zum Zitat Earle CC, Schrag D, Neville BA, et al. Effect on surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98:172–80.PubMedCrossRef Earle CC, Schrag D, Neville BA, et al. Effect on surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98:172–80.PubMedCrossRef
35.
Zurück zum Zitat Muntz HG. “Curbside” consultations in gynecologic oncology: a closer look at a common practice. Gynecol Oncol. 1999;74:456–9.CrossRefPubMed Muntz HG. “Curbside” consultations in gynecologic oncology: a closer look at a common practice. Gynecol Oncol. 1999;74:456–9.CrossRefPubMed
Metadaten
Titel
Analysis of Contemporary Trends in Access to High-Volume Ovarian Cancer Surgical Care
verfasst von
Robert E. Bristow, MD, FACS
Isha Puri, MD
Teresa P. Diaz-Montes, MD, MPH
Robert L. Giuntoli, MD, FACS
Deborah K. Armstrong, MD
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2009
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0680-5

Weitere Artikel der Ausgabe 12/2009

Annals of Surgical Oncology 12/2009 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.